Sorry, you need to enable JavaScript to visit this website.


Department of Health Care Finance - DHCF

DC Agency Top Menu

-A +A
Bookmark and Share

Transmittal 21-10 Chronic Hepatitis C Treatment Coverage Policy: Removal of Minimum Fibrosis Score Requirement

Monday, March 1, 2021

The purpose of this transmittal is to outline the policy change that the District Medicaid program will implement effective March 1, 2021 for orally administered Direct Acting Antivirals (DAAs) used in the current treatment of chronic Hepatitis C infection for Medicaid [Fee for Service (FFS) and managed care (MCO)] enrolled beneficiaries.